When a Wound Won't Heal and Tests Come Back "Normal"
Imagine a serious skin or wound infection that's spreading, but every lab culture comes back negative. It happens more than most people realize. The bacteria causing the problem simply don't grow well under standard laboratory conditions — or they're buried among multiple species that the culture process can't sort out.
For patients, that means days of broad-spectrum antibiotics that may be hitting the wrong target.
Why Standard Cultures Fall Short
Traditional microbiology relies on growing bacteria in a lab dish. It's been used for over a century and still works well for many common infections. But it has real limitations.
It misses organisms that don't grow easily in standard conditions. It struggles when multiple bacteria are present at once (called polymicrobial infections). And results can take days — time that matters in a spreading infection.
A New Kind of Test Reads the DNA Itself
Metagenomic next-generation sequencing (mNGS) takes a completely different approach. Instead of trying to grow anything, it reads all the genetic material present in a sample — bacteria, fungi, viruses — and identifies them by their DNA fingerprint.
Think of it like the difference between trying to find a specific book by searching shelf by shelf (standard culture) versus scanning every page of every book in the library at once (mNGS). The sequencing approach finds things that the manual search would take days to reach — or miss entirely.
The Study Behind the Numbers
Researchers at a hospital in China reviewed 69 patients with complex skin and soft tissue infections between 2023 and 2025. Every patient received both mNGS testing and standard bacterial culture. The results were compared directly.
What the Tests Found — and Didn't Find
The gap between the two methods was striking. Standard cultures failed to identify any pathogen in 24 of the 69 patients. In those same 24 cases, mNGS found the culprit in 20 of them — an 83% detection rate in cases where conventional testing came back empty.
For infections caused by multiple bacteria at once, the difference was even more dramatic. Among 20 polymicrobial cases, standard culture identified pathogens in only 2. mNGS successfully identified multiple organisms in the majority.
Here's Where It Gets Complicated
But there's a catch.
Only 8 out of 69 patients (about 12%) actually had their antibiotic treatment adjusted based on the mNGS results. This suggests that while the test detects more, translating that detection into different treatment decisions is still a work in progress. Not every organism found necessarily needs to be treated.
What Infection Specialists Are Thinking
The field of infectious disease is grappling with the gap between what mNGS can detect and what clinicians should act on. The technology is powerful — but it also picks up incidental organisms, colonizers, and fragments of genetic material that don't always represent active infection. Interpreting mNGS results requires expertise, and guidelines for clinical use are still being developed.
If you or a loved one is dealing with a serious wound or skin infection that hasn't responded to initial treatment and standard cultures keep coming back negative, mNGS testing may be worth asking about. It's not available everywhere, and it's not cheap, but it can provide answers when conventional testing fails.
mNGS testing is not a standard part of routine infection workup yet — its use is currently limited to complex or treatment-resistant cases at specialized centers.
Limitations to Keep in Mind
This was a small retrospective study at a single center. With only 69 patients, the findings are preliminary. The study also comes from a hospital in China, where pathogen patterns and antibiotic resistance profiles may differ from other regions. And while detection improved, the study wasn't designed to measure whether patient outcomes actually improved as a result.
Larger prospective studies are underway to determine whether mNGS-guided antibiotic selection leads to better clinical outcomes — faster healing, shorter hospital stays, fewer complications. As costs come down and interpretation guidelines improve, this technology could move from a specialized tool to a more routine part of managing difficult infections.